Skip to Main Content
Back to News

Fund Update: AustralianSuper Pty Ltd opened a $77.9M position in $APH stock

None

AustralianSuper Pty Ltd has opened a new $77.9M position in $APH, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $APH.

$APH Hedge Fund Activity

We have seen 783 institutional investors add shares of $APH stock to their portfolio, and 659 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$APH Insider Trading Activity

$APH insiders have traded $APH stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $APH stock by insiders over the last 6 months:

  • LUC WALTER (President, HES Division) sold 286,000 shares for an estimated $26,148,522
  • WILLIAM J DOHERTY (President, CS Division) has made 0 purchases and 3 sales selling 286,000 shares for an estimated $24,442,422.
  • LANCE E D'AMICO (Sr. VP, Secretary & GenCounsel) has made 0 purchases and 3 sales selling 305,000 shares for an estimated $24,271,185.
  • DAVID M SILVERMAN (Senior VP, Human Resources) has made 0 purchases and 2 sales selling 187,500 shares for an estimated $15,912,316.
  • MICHAEL R. IVAS (VP & Corporate Controller) sold 40,000 shares for an estimated $3,551,408

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$APH Congressional Stock Trading

Members of Congress have traded $APH stock 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $APH stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$APH Analyst Ratings

Wall Street analysts have issued reports on $APH in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • UBS issued a "Buy" rating on 07/24/2025
  • JP Morgan issued a "Overweight" rating on 07/24/2025
  • Citigroup issued a "Buy" rating on 07/24/2025
  • Truist Securities issued a "Buy" rating on 07/24/2025
  • Baird issued a "Outperform" rating on 07/24/2025
  • Evercore ISI Group issued a "Outperform" rating on 07/18/2025
  • Goldman Sachs issued a "Buy" rating on 06/10/2025

To track analyst ratings and price targets for $APH, check out Quiver Quantitative's $APH forecast page.

$APH Price Targets

Multiple analysts have issued price targets for $APH recently. We have seen 9 analysts offer price targets for $APH in the last 6 months, with a median target of $118.0.

Here are some recent targets:

  • Chris Snyder from UBS set a target price of $120.0 on 07/24/2025
  • Asiya Merchant from Citigroup set a target price of $125.0 on 07/24/2025
  • Samik Chatterjee from JP Morgan set a target price of $125.0 on 07/24/2025
  • Luke Junk from Baird set a target price of $118.0 on 07/24/2025
  • William Stein from Truist Securities set a target price of $126.0 on 07/24/2025
  • Amit Daryanani from Evercore ISI Group set a target price of $110.0 on 07/18/2025
  • Mark Delaney from Goldman Sachs set a target price of $102.0 on 06/10/2025

Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.

Check out Quiver Quantitative's $APH ticker page for more data.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles